Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma

[1]  Minu P. Mohan,et al.  Prevention and treatment of oral mucositis pain following cancer therapy , 2018, Drugs & Therapy Perspectives.

[2]  T. Onitsuka,et al.  Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer. , 2015, Japanese journal of clinical oncology.

[3]  S. Dermime,et al.  The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone. , 2014, Hematology/oncology and stem cell therapy.

[4]  R. Riera,et al.  Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Kana Takahashi,et al.  Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab , 2014, Journal of Cancer Research and Clinical Oncology.

[6]  R. Knecht,et al.  New treatment strategies for HPV-positive head and neck cancer , 2014, European Archives of Oto-Rhino-Laryngology.

[7]  Li Lin,et al.  Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma? , 2013 .

[8]  P. Franco,et al.  Management of ‘In-Field' Skin Toxicity in Head and Neck Cancer Patients Treated with Combined Cetuximab and Radiotherapy , 2013, Oncology.

[9]  J. Bourhis,et al.  Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  T. Akimoto,et al.  Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck , 2013, Japanese journal of clinical oncology.

[11]  G. Calais,et al.  Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Wei Xu,et al.  Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  G. Wu,et al.  PO-077: Cetuximab Plus Radiotherapy for Chinese Patients with Locally Advanced Head and Neck Cancer , 2013 .

[14]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[15]  M. Tahara,et al.  A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study , 2013, International Journal of Clinical Oncology.

[16]  D. Tsan,et al.  The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity , 2012, Radiation oncology.

[17]  S. Kannan,et al.  Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  P. Thongsuksai,et al.  Survival and prognostic factors of different sites of head and neck cancer: an analysis from Thailand. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[19]  T. Akimoto,et al.  Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  J. Bernier,et al.  Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[22]  Jordi Giralt,et al.  Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. , 2010, The Lancet. Oncology.

[23]  A. Balan,et al.  Radiation Induced Oral Mucositis , 2009, Indian journal of palliative care.

[24]  E. Karapanagiotou,et al.  Head and neck cancer in the elderly: an overview on the treatment modalities. , 2009, Cancer treatment reviews.

[25]  A. Garden,et al.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  K. Ang,et al.  Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  D. McGuire,et al.  Clinical Practice Guidelines for the Prevention and Treatment of Mucositis , 2007 .

[28]  Christopher U. Jones,et al.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.

[29]  A. Munshi,et al.  Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  G. V. Ramana,et al.  Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer. , 2004, Neoplasia.

[31]  L. Elting,et al.  Perspectives on cancer therapy‐induced mucosal injury , 2004, Cancer.

[32]  D. McGuire,et al.  Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis , 2004, Cancer.

[33]  J. Wilkes.  Prevention and treatment of oral mucositis following cancer chemotherapy. , 1998, Seminars in oncology.

[34]  T. Wendt,et al.  Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  A. Boyle,et al.  A convenient method for guarding against localized mucositis during radiation therapy. , 1994, Journal of Prosthodontics.

[36]  C. Verdi.  Cancer Therapy and Oral Mucositis , 1993, Drug safety.

[37]  R. Henriksson,et al.  Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. , 1992, European journal of cancer.